Mursla Bio selected as UK Life Sciences Innovator 2023
Mursla Bio was selected by the UK Department of International Trade to represent UK excellence across the life sciences sector
Mursla Bio invited to present at the Festival of Genomics and Biodata
Mursla Bio’s cutting edge expertise in extracellular vesicle biology is to be showcased at the world’s largest genomics event
Dr Karin Schmitt joins Mursla Bio as Chief Operating Officer
Mursla adds seasoned executive with a wealth of experience in rapid growth and product commercialisation to leadership team
Mursla Bio unveils new bead-nanochip technology for ultrasensitive and high throughput EV detection
Novel technology further establishes Mursla Bio’s capabilities to uniquely analyse extracellular vesicle biology for clinical translation
Mursla Bio gains support of Roche Diagnostics for pilot study in liver cancer patients
Access to Roche Diagnostics’ expertise in the UK secured in recognition of Mursla’s differentiated value proposition for liquid biopsy